Pathogenethic aspects of involutional osteoporosis G. F. MazzuoliE. D'erasmoG. Bianchi OriginalPaper Pages: 22 - 29
BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis A. RapadoC. De La PiedraR. Torres OriginalPaper Pages: 30 - 34
Isotope retention for assessment of bone turnover in involutional osteoporosis M. PasseriE. PalummeriD. Ugolotti OriginalPaper Pages: 35 - 40
Noninvasive methods of bone-mass measurement J. P. SabatierG. Guaydier-Souquieres OriginalPaper Pages: 41 - 45
New methods for identifying “at risk” patients for osteoporosis C. ChristiansenB. J. Riis OriginalPaper Pages: 52 - 55
ADFR therapy in the prevention of bone loss after menopause R. Pérez CanoR. MorunoM. Garrido OriginalPaper Pages: 56 - 60
Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis C. Gennari OriginalPaper Pages: 61 - 65
The natural history of the osteoporotic vertebral fracture G. P. LyritisB. MayasisA. Yiatzides OriginalPaper Pages: 66 - 69
The role of physical exercise in prevention and management of osteoporosis G. DilşenC. BerkerG. Varan OriginalPaper Pages: 70 - 75
Secondary osteoporosis and the microanatomy of trabecular bone J. E. AaronD. R. JohnsonJ. A. Kanis OriginalPaper Pages: 84 - 88
Concept and limits of the reflex sympathetic dystrophy D. Roig-EscofetJ. Rodriguez-MorenoJ. M. Ruiz Martin OriginalPaper Pages: 104 - 108
The osteoporosis of heparinotherapy and systemic mastocytosis T. BardinM. Lequesne OriginalPaper Pages: 119 - 123